Global  

Trusted News Discovery Since 2008
One News Page
One News Page > World News > Covid 19 coronavirus: Experimental Ebola drug could treat Covid-19 patients in clinical trial

Covid 19 coronavirus: Experimental Ebola drug could treat Covid-19 patients in clinical trial

New Zealand Herald Thursday, 26 March 2020 ()
Covid 19 coronavirus: Experimental Ebola drug could treat Covid-19 patients in clinical trialSign up to our daily Covid-19 newsletter for essential advice and a full summary of the day's news and developments. Register or sign in here and select Top News Stories An experimental drug initially designed to treat Ebola...
0
shares
ShareTweetSavePostSend
 
Credit: CBS 5 SF KPIX - Published < > Embed
News video: Genentech to Begin Clinical Trial of Drug Treatment for COVID-19

Genentech to Begin Clinical Trial of Drug Treatment for COVID-19 01:54

KPIX 5 spoke to Dr. Levi Garraway, chief medical officer at Genentech, about a pending clinical trial of Actemra, an anti-inflammatory medicine, as a possible treatment for COVID-19 patients. (3-27-20)

You Might Like


Recent related videos from verified sources

Health Headlines - 4-2-20 [Video]

Health Headlines - 4-2-20

In today's health headlines we talk about a Coronavirus vaccine that will be moving to human trials. More than 2000 ventilators can't be sent because of how they were maintained. A nurse shares what..

Credit: FOX 47 News Michigan     Duration: 03:13Published
Detroit to be first U.S. site for new COVID-10 drug trial [Video]

Detroit to be first U.S. site for new COVID-10 drug trial

Detroit to be first U.S. site for new COVID-10 drug trial

Credit: WXYZ Detroit     Duration: 01:59Published

Recent related news from verified sources

Humanigen poised to partner with leading contract research organization on Phase III trial to tackle deadly coronavirus

Humanigen Inc (OTCMKTS:HGEN) shares rose on Monday as it announced that it will partner with contract research organization, CTI Clinical Trial and Consulting...
Proactive Investors

Exclusive: Sanofi can produce millions of doses of potential coronavirus drug - CEO

Sanofi SA will be able to provide millions of doses of hydroxychloroquine for patients with the illness caused by the novel coronavirus if the old malaria drug...
Reuters Also reported by •Proactive Investors

Tweets about this

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2020 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.